The year in cardiovascular medicine 2021: diabetes and metabolic disorders

被引：11

作者：

Cosentino, Francesco ^{[1
,2
]}

Bhatt, Deepak L. ^{[3
]}

Marx, Nikolaus ^{[4
]}

Verma, Subodh ^{[5
,6
,7
,8
]}

机构：

[1] Karolinska Inst, Dept Med Solna, Cardiol Unit, SE-17177 Stockholm, Sweden

[2] Karolinska Univ Hosp, SE-17177 Stockholm, Sweden

[3] Harvard Med Sch, Brigham & Womens Hosp, Dept Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA

[4] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Internal Med, Aachen, Germany

[5] Univ Toronto, Dept Pharmacol & Toxicol, 27 Kings Coll Circle, Toronto, ON M5S 3J3, Canada

[6] St Michaels Hosp, Div Cardiovasc Surg, 30 Bond St, Toronto, ON M5B 1W8, Canada

[7] Univ Toronto, Inst Med Sci, 27 Kings Coll Circle, Toronto, ON M5S 3J3, Canada

[8] Univ Toronto, Dept Surg, 27 Kings Coll Circle, Toronto, ON M5S 3J3, Canada

来源：

EUROPEAN HEART JOURNAL | 2022年 / 43卷 / 04期

关键词：

Diabetes mellitus; Obesity; Heart failure; GLP-1 receptor agonists; SGLT2; inhibitors; Aldosterone receptor antagonism; Omega-3 fatty acid mixtures; HEART-FAILURE; EJECTION FRACTION; EMPAGLIFLOZIN; OUTCOMES; DISEASE; EVENTS; PEOPLE;

D O I：

10.1093/eurheartj/ehab876

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In the current paper, we review recently published studies that are helping us to understand how the treatment landscape for glucagon-like peptiide-1 receptor agonists and sodium glucose cotransporter 2 inhibitors is moving forward. We have also included relevant articles related to cardiovascular disease prevention in the setting of obesity, atherogenic dyslipidaemia and chronic kidney disease.

引用

页码：263 / 270

页数：8

共 29 条

[1] Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes [J].

Abraham, William T. ;

Lindenfeld, JoAnn ;

Ponikowski, Piotr ;

Agostoni, Piergiuseppe ;

Butler, Javed ;

Desai, Akshay S. ;

Filippatos, Gerasimos ;

Gniot, Jacek ;

Fu, Michael ;

Gullestad, Lars ;

Howlett, Jonathan G. ;

Nicholls, Stephen J. ;

Redon, Josep ;

Schenkenberger, Isabelle ;

Silva-Cardoso, Jose ;

Stoerk, Stefan ;

Wranicz, Jerzy Krzysztof ;

Savarese, Gianluigi ;

Brueckmann, Martina ;

Jamal, Waheed ;

Nordaby, Matias ;

Peil, Barbara ;

Ritter, Ivana ;

Ustyugova, Anastasia ;

Zeller, Cordula ;

Salsali, Afshin ;

Anker, Stefan D. .

EUROPEAN HEART JOURNAL, 2021, 42 (06) :700-U172

[2] Empagliflozin in Heart Failure with a Preserved Ejection Fraction [J].

Anker, Stefan D. ;

Butler, Javed ;

Filippatos, Gerasimos ;

Ferreira, Joao P. ;

Bocchi, Edimar ;

Boehm, Michael ;

Brunner-La Rocca, Hans-Peter ;

Choi, Dong-Ju ;

Chopra, Vijay ;

Chuquiure-Valenzuela, Eduardo ;

Giannetti, Nadia ;

Gomez-Mesa, Juan Esteban ;

Janssens, Stefan ;

Januzzi, James L. ;

Gonzalez-Juanatey, Jose R. ;

Merkely, Bela ;

Nicholls, Stephen J. ;

Perrone, Sergio V. ;

Pina, Ileana L. ;

Ponikowski, Piotr ;

Senni, Michele ;

Sim, David ;

Spinar, Jindrich ;

Squire, Iain ;

Taddei, Stefano ;

Tsutsui, Hiroyuki ;

Verma, Subodh ;

Vinereanu, Dragos ;

Zhang, Jian ;

Carson, Peter ;

Lam, Carolyn Su Ping ;

Marx, Nikolaus ;

Zeller, Cordula ;

Sattar, Naveed ;

Jamal, Waheed ;

Schnaidt, Sven ;

Schnee, Janet M. ;

Brueckmann, Martina ;

Pocock, Stuart J. ;

Zannad, Faiez ;

Packer, Milton .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1451-1461

[3] Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status Results From the EMPEROR-Reduced Trial [J].

Anker, Stefan D. ;

Butler, Javed ;

Filippatos, Gerasimos ;

Khan, Muhammad Shahzeb ;

Marx, Nikolaus ;

Lam, Carolyn S. P. ;

Schnaidt, Sven ;

Ofstad, Anne Pernille ;

Brueckmann, Martina ;

Jamal, Waheed ;

Bocchi, Edimar A. ;

Ponikowski, Piotr ;

Perrone, Sergio, V ;

Januzzi, James L. ;

Verma, Subodh ;

Boehm, Michael ;

Ferreira, Joao Pedro ;

Pocock, Stuart J. ;

Zannad, Faiez ;

Packer, Milton .

CIRCULATION, 2021, 143 (04) :337-349

[4] Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes [J].

Bakris, George L. ;

Agarwal, Rajiv ;

Anker, Stefan D. ;

Pitt, Bertram ;

Ruilope, Luis M. ;

Rossing, Peter ;

Kolkhof, Peter ;

Nowack, Christina ;

Schloemer, Patrick ;

Joseph, Amer ;

Filippatos, Gerasimos .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) :2219-2229

[5] Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure [J].

Bhatt, Deepak L. ;

Szarek, Michael ;

Steg, P. Gabriel ;

Cannon, Christopher P. ;

Leiter, Lawrence A. ;

McGuire, Darren K. ;

Lewis, Julia B. ;

Riddle, Matthew C. ;

Voors, Adriaan A. ;

Metra, Marco ;

Lund, Lars H. ;

Komajda, Michel ;

Testani, Jeffrey M. ;

Wilcox, Christopher S. ;

Ponikowski, Piotr ;

Lopes, Renato D. ;

Verma, Subodh ;

Lapuerta, Pablo ;

Pitt, Bertram .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) :117-128

[6] Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease [J].

Bhatt, Deepak L. ;

Szarek, Michael ;

Pitt, Bertram ;

Cannon, Christopher P. ;

Leiter, Lawrence A. ;

McGuire, Darren K. ;

Lewis, Julia B. ;

Riddle, Matthew C. ;

Inzucchi, Silvio E. ;

Kosiborod, Mikhail N. ;

Cherney, David Z. I. ;

Dwyer, Jamie P. ;

Scirica, Benjamin M. ;

Bailey, Clifford J. ;

Diaz, Rafael ;

Ray, Kausik K. ;

Udell, Jacob A. ;

Lopes, Renato D. ;

Lapuerta, Pablo ;

Steg, P. Gabriel .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) :129-139

[7] Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease Insights From the COMPASS Trial [J].

Bhatt, Deepak L. ;

Eikelboom, John W. ;

Connolly, Stuart J. ;

Steg, P. Gabriel ;

Anand, Sonia S. ;

Verma, Subodh ;

Branch, Kelley R. H. ;

Probstfield, Jeffrey ;

Bosch, Jackie ;

Shestakovska, Olga ;

Szarek, Michael ;

Maggioni, Aldo Pietro ;

Widimsky, Petr ;

Avezum, Alvaro ;

Diaz, Rafael ;

Lewis, Basil S. ;

Berkowitz, Scott D. ;

Fox, Keith A. A. ;

Ryden, Lars ;

Yusuf, Salim .

CIRCULATION, 2020, 141 (23) :1841-1854

[8] A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial [J].

Brown, Alexander J. M. ;

Gandy, Stephen ;

McCrimmon, Rory ;

Houston, John Graeme ;

Struthers, Allan D. ;

Lang, Chim C. .

EUROPEAN HEART JOURNAL, 2020, 41 (36) :3421-3432

[9] Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial [J].

Butler, Javed ;

Anker, Stefan D. ;

Filippatos, Gerasimos ;

Khan, Muhammad Shahzeb ;

Ferreira, Joao Pedro ;

Pocock, Stuart J. ;

Giannetti, Nadia ;

Januzzi, James L. ;

Pina, Ileana L. ;

Lam, Carolyn S. P. ;

Ponikowski, Piotr ;

Sattar, Naveed ;

Verma, Subodh ;

Brueckmann, Martina ;

Jamal, Waheed ;

Vedin, Ola ;

Peil, Barbara ;

Zeller, Cordula ;

Zannad, Faiez ;

Packer, Milton .

EUROPEAN HEART JOURNAL, 2021, 42 (13) :1203-1212

[10] Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes [J].

Cannon, Christopher P. ;

Pratley, Richard ;

Dagogo-Jack, Samuel ;

Mancuso, James ;

Huyck, Susan ;

Masiukiewicz, Urszula ;

Charbonnel, Bernard ;

Frederich, Robert ;

Gallo, Silvina ;

Cosentino, Francesco ;

Shih, Weichung J. ;

Gantz, Ira ;

Terra, Steven G. ;

Cherney, David Z. I. ;

McGuire, Darren K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) :1425-1435

← 1 2 3 →